Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06964113) titled 'A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice' on May 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Eisai Korea Inc.
Condition:
Ulcerative Colitis
Intervention:
Drug: Filgotinib Maleate...
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: June 30, 2025
Target Sample Size: 94
Countries of Recruitment:
Korea, Republic of
To know more, visit https://clinicalt...